FHTX - Foghorn Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FHTX is currently covered by 5 analysts with an average price target of $11.17. This is a potential upside of $7 (167.87%) from yesterday's end of day stock price of $4.17.

Foghorn Therapeutics 's activity chart (see below) currently has 31 price targets and 30 ratings on display. The stock rating distribution of FHTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.41% with an average time for these price targets to be met of 19.6 days.

Highest price target for FHTX is $14, Lowest price target is $9, average price target is $13.6.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 07-Mar-2025. First documented stock forecast 17-Nov-2020.

Best performing analysts who are covering FHTX - Foghorn Therapeutics :

Vikram Purohit Andrew Fein Robert Driscoll Paul Choi Kelly Shi

Currently out of the existing stock ratings of FHTX, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$8.92 (218.63%)

$13

2 months 26 days ago
(07-Mar-2025)

2/13 (15.38%)

$8.5 (188.89%)

43

Buy

$14

$9.92 (243.14%)

$18

5 months 17 days ago
(16-Dec-2024)

0/2 (0%)

$8.49 (154.08%)

$9

$4.92 (120.59%)

$6

8 months 9 days ago
(24-Sep-2024)

3/10 (30%)

$-0.56 (-5.86%)

25

Buy

$13

$8.92 (218.63%)

$14

9 months 24 days ago
(09-Aug-2024)

1/6 (16.67%)

$7.75 (147.62%)

30

Buy

$19

$14.92 (365.69%)

$28

1 years 11 months 4 days ago
(29-Jun-2023)

0/3 (0%)

$10.81 (131.99%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FHTX (Foghorn Therapeutics ) average time for price targets to be met?

On average it took 19.6 days on average for the stock forecasts to be realized with a an average price target met ratio 12.41

Which analyst has the current highest performing score on FHTX (Foghorn Therapeutics ) with a proven track record?

VIKRAM PUROHIT

Which analyst has the current lower performing score on FHTX (Foghorn Therapeutics ) with a proven track record?

KELLY SHI

Which analyst has the most public recommendations on FHTX (Foghorn Therapeutics )?

Vikram Purohit works at MORGAN STANLEY and has 5 price targets and 1 ratings on FHTX

Which analyst is the currently most bullish on FHTX (Foghorn Therapeutics )?

Paul Choi with highest potential upside - $14.92

Which analyst is the currently most reserved on FHTX (Foghorn Therapeutics )?

Vikram Purohit with lowest potential downside - $4.92

Foghorn Therapeutics  in the News

Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced the election of Neil Gallagher, M.D., Ph.D., and Stuart Duty, to its Board of Directors. “Neil and Stuart are experienced leaders...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?